-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on Immunocore Holdings, Lowers Price Target to $42

Benzinga·11/13/2026 18:06:03
Morgan Stanley analyst Sean Laaman maintains Immunocore Holdings (NASDAQ:IMCR) with a Equal-Weight and lowers the price target from $43 to $42.